Research Roundup: What we’re reading this week
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Secretary of State Hillary Rodham Clinton unveiled a blueprint for achieving an AIDS-free generation, which recognizes the need for research to develop new HIV and AIDS treatment and prevention tools.
A new tuberculosis vaccine candidate has been given regulatory approval to begin clinical trials in Europe, making it the first of its kind to do so.
An experimental vaccine based on a molecule that protects animals against influenza may one day offer a faster way to develop new vaccines for humans.
At a recent World Health Organization meeting, member states agreed to focus on strengthening national regulatory capacities as part of a plan to promote the prevention and control of substandard medical products worldwide. In related news, WHO member states have also agreed to endorse a strategic work plan for global health research that includes proposals on the coordination, financing, and monitoring of research expenditures.
A new report from the Milken Institute explores possible incentives and innovative financing mechanisms to develop treatments for diseases that primarily affect the developing world.